DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Krop IE, Guardino E et al.
Efficacy and safety of T-Dm1 versus lapatinib plus capecitabine in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer and central nervous metastases: results from a retrospective exploratory analysis of EMILIA.
Poster Presentation SABCS 2013: P4–12–27
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.